Low-dose botulinum toxin injections for jaw, facial pain not linked to short-term bone changes
FRIDAY, Sept. 18, 2020 (HealthDay News) — Jaw bone density and volume are similar between women who had botulinum toxin (BTX) injections to treat temporomandibular muscle and joint disorders (TMJDs) and those who did not, according to a small study published online Sept. 3 in the Journal of Oral Rehabilitation.
Karen G. Raphael, Ph.D., from the New York University College of Dentistry in New York City, and colleagues compared TMJ bone density and mandibular condylar volume between 35 patients with myofascial TMJD receiving multiple masticatory muscle BTX treatments and 44 similarly diagnosed women not receiving BTX.
The researchers found that the mean density of primary and secondary regions of interest was similar between exposure groups, as was condylar volume. An increasing dose of BTX to the temporalis muscle was inversely proportional to the density of the trabecular area of the mandible body. Many women treated in community-based practices received smaller doses of BTX to the masseter muscles than in most TMJD BTX clinical trials.
“Unless specialized imaging of muscle and bone are conducted among patients who receive BTX treatment over long periods, true cumulative adverse effects will remain unknown,” the authors write.
Abstract/Full Text (subscription or payment may be required)
First Metatarsophalangeal Joint Arthrodesis Eases Painful Hallux Rigidus 
2005 to 2023 Saw Decrease in DXA Testing for Osteoporosis Screening 
Botox Helpful in Alleviating Chronic Migraine in Pediatric Patients 
Review Reveals Limited Effects of Exercise on Hip Osteoarthritis 
Stair Climbing Associated With Reduction in Cardiovascular, All-Cause Mortality 
Physical Activity Reduces Stroke, Mortality, Regardless of A-Fib 
Platelet-Rich Plasma, Shockwave Therapy Show Therapeutic Efficacy in Interstitial Cystitis 
Swimming Program May Provide Short-Term Relief From Chronic Low Back Pain 
